Oh boy, a report that combines two of my favorite entities in the health care world–hospitals and drug companies. (PHAR Report) The report looks specifically at payments by private health plans for physician-administered drugs, with the administration occurring in a hospital outpatient setting. It is a well-known abusive practice for hospitals to employ or acquire physicians and then jack up prices for their services. This category of drugs, which tends to be very expensive and is often used for cancer, arthritis and similar serious conditions, has seen a lot of misuse in this regard. In addition to their general inclination to raise the prices for these medications, hospitals also sometimes get special pricing on them through programs like 340B, which lowers their cost and raises profits. According to the report, 47% of patients receiving a physician-administered drug get it in a doctor’s office and 53% in a hospital outpatient department. But hospitals keep 91% of all gross profits earned from the use of these drugs, while physicians get only 9%. Shows you how great the spread in prices must be. Furthermore, for every $100 spent on physician-administered drugs in the hospital setting, hospitals keep $58 while their cost, or the payment to the drugs’ manufacturer, represents only $42. That $58 is basically all profit to the hospital–the costs related to the labor, etc. involved in administering the drug is paid by a separate fee. So this is a line of business which is immensely profitable to hospitals, most of them supposedly non-profits, and which greatly raises costs to private health plans and to the members they serve, who often have extensive deductibles and copayments. If you are a member of a non-profit health system’s board, and supposedly representing the public interest, I don’t know how you sleep at nite. I know how the executives of these systems do–on pillows stuffed with cash from the excessive compensation they get as a result of the excessive prices the hospitals charge.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Mental health company Headway makes, well, headway, by raising an impressive $125 million round of new capital. The company connects patients with mental health providers and facilitates providers working with...
October 11, 2023
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace